Navigation Links
BioTrends Research Group is Recognized by the Philly 100 for the Second Consecutive Year
Date:9/8/2009

tom market research to pharmaceutical manufacturers competing in clinically evolving, specialty pharmaceutical markets. To learn more, please contact us at (610) 363-3872 or visit us at www.bio-trends.com

About the Philly 100

For more information on the Philadelphia 100, visit www.philadelphia100.com.

CONTACT: Jennifer Robinson of BioTrends Research Group, Inc., +1-610-363-3872, jrobinson@bio-trends.com


'/>"/>
SOURCE BioTrends Research Group, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Raptiva Withdrawal Offers Upside for Enbrel and Humira According to Latest BioTrends Survey of U.S. Dermatologists
2. Latest BioTrends Research Reports to Assess the Impact of the Withdrawal of Raptiva (efalizumab) on the Psoriasis Market
3. BioTrends Releases TreatmentTrends(TM): US Nephrology, an Ongoing Syndicated Publication Providing Insight into Physician Perceptions and Management of Renal Anemia, Hyperphosphatemia, and Secondary Hyperparathyroidism
4. European Nephrologists Share Insights on the Management of Renal Anemia and Hyperphosphatemia in Latest BioTrends Report
5. BioTrends Releases TreatmentTrends(TM): Nephrology and Renal Dietitians, Two Syndicated Reports Providing Continuing Insight into the Management of Renal Anemia, Hyperphosphatemia, and Secondary Hyperparathyroidism
6. BioTrends Research Group, Inc. Recognized as One of Philadelphias Fastest Growing Privately Held Companies
7. New Study by BioTrends Highlights Anemia Practice Patterns According to Anemia Managers in Both Dialysis Units and CKD Clinics/Offices
8. BioTrends Releases Quarterly TreatmentTrends(TM): Nephrology Report Highlighting Market Trends for Renal Anemia, Hyperphosphatemia, and Secondary Hyperparathyroidism
9. New Study by BioTrends Highlights Practice Management Shifts Among European Nephrologists
10. BioTrends Releases Two Publications - TreatmentTrends(TM): Nephrologists and TreatmentTrends(TM): Renal Dietitians - Highlighting Market Trends for Renal Anemia, Hyperphosphatemia, and Secondary Hyperparathyroidism
11. BioTrends Releases Fourth Annual Nephrology TreatmentTrends Publication Highlighting Market Trends for Renal Anemia, Hyperphosphatemia, and Secondary Hyperparathyroidism
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... months after the Nanyang Technological University (NTU) signed ... National Center for Scientific Research (CNRS) and the ... joint research laboratory, the three parties are meeting ... Alliance (CINTRA) Laboratory at NTU. , Located ... aims to harness the latest in science and ...
(Date:12/16/2009)... -- Cord Blood America, Inc. (OTC Bulletin Board: ... company ( http://www.cordblood-america.com ) focused on bringing ... biological insurance policy, to families nationwide and internationally, ... by a total of $1.4 million so far ... debt eliminated for the year now tops $10 ...
(Date:12/16/2009)... Assessment with the Food and Drug Administration ... AEterna Zentaris Inc. (NASDAQ: AEZS ; ... company focused on oncology and endocrine therapy, ... Keryx Biopharmaceuticals Inc. ("Keryx") ( KERX), of ... perifosine (KRX-0401), the Company,s PI3K/Akt pathway inhibitor, ...
(Date:12/15/2009)... -- Epeius Biotechnologies Corporation, an emerging leader in ... validation of the cutting-edge science behind its lead ... the world rediscovered the Cyclin G1 gene ... pathogenesis and disease progression, and thus a prime ... NIH National Cancer Institute investigating the role of ...
Breaking Biology Technology:New Singapore-French nanotech lab opens at NTU 2New Singapore-French nanotech lab opens at NTU 3Cord Blood America Says 2009 Debt Reduction Tops $10 Million 2Cord Blood America Says 2009 Debt Reduction Tops $10 Million 3AEterna Zentaris Partner, Keryx, Initiates Phase 3 Registration Trial with Perifosine (KRX-0401) for the Treatment of Patients with Advanced Multiple Myeloma 2AEterna Zentaris Partner, Keryx, Initiates Phase 3 Registration Trial with Perifosine (KRX-0401) for the Treatment of Patients with Advanced Multiple Myeloma 3AEterna Zentaris Partner, Keryx, Initiates Phase 3 Registration Trial with Perifosine (KRX-0401) for the Treatment of Patients with Advanced Multiple Myeloma 4AEterna Zentaris Partner, Keryx, Initiates Phase 3 Registration Trial with Perifosine (KRX-0401) for the Treatment of Patients with Advanced Multiple Myeloma 5Scientists Rediscover Gene Target for Cancer Therapy 2Scientists Rediscover Gene Target for Cancer Therapy 3
... Leader says “Right Product, Right Acre” Key to Top Productivity. ... ... As seed technologies advance, matching specific genetic technologies to individual management ... S. Niebur , vice president -- DuPont Crop Genetics Research and ...
... Identify Potential Initiation Dosing Regimen , ... palmitate, an investigational long-acting therapy (LAT) demonstrated statistically significant ... of a 13-week study presented today (1). Statistical ... and 150 mg equivalent [eq.a]), when given every 4 ...
... Journal Blood for the American Society of Hematology Annual Meeting ... 10 Alfacell Corporation (Nasdaq: ACEL ) today ... in Blood (2008 112: Abstract 4205 & 2008 ... show anti-tumor activity in chronic lymphocytic leukemia (CLL) and acute ...
Other Biology Technology:Matching Genetics, Technology and Management Practices Critical to Meeting Strong Demand for Agricultural Crops 2Matching Genetics, Technology and Management Practices Critical to Meeting Strong Demand for Agricultural Crops 3Matching Genetics, Technology and Management Practices Critical to Meeting Strong Demand for Agricultural Crops 4Phase 3 Data Demonstrate Efficacy and Tolerability of Paliperidone Palmitate, an Investigational Long-Acting Therapy for the Treatment of Schizophrenia 2Phase 3 Data Demonstrate Efficacy and Tolerability of Paliperidone Palmitate, an Investigational Long-Acting Therapy for the Treatment of Schizophrenia 3Phase 3 Data Demonstrate Efficacy and Tolerability of Paliperidone Palmitate, an Investigational Long-Acting Therapy for the Treatment of Schizophrenia 4Phase 3 Data Demonstrate Efficacy and Tolerability of Paliperidone Palmitate, an Investigational Long-Acting Therapy for the Treatment of Schizophrenia 5Phase 3 Data Demonstrate Efficacy and Tolerability of Paliperidone Palmitate, an Investigational Long-Acting Therapy for the Treatment of Schizophrenia 6Phase 3 Data Demonstrate Efficacy and Tolerability of Paliperidone Palmitate, an Investigational Long-Acting Therapy for the Treatment of Schizophrenia 7Phase 3 Data Demonstrate Efficacy and Tolerability of Paliperidone Palmitate, an Investigational Long-Acting Therapy for the Treatment of Schizophrenia 8Phase 3 Data Demonstrate Efficacy and Tolerability of Paliperidone Palmitate, an Investigational Long-Acting Therapy for the Treatment of Schizophrenia 9Alfacell's ONCONASE(R) and R-Amphinase Show Anti-Tumor Activity in Chronic Lymphocytic Leukemia and Acute Myeloblastic Leukemia Cells 2Alfacell's ONCONASE(R) and R-Amphinase Show Anti-Tumor Activity in Chronic Lymphocytic Leukemia and Acute Myeloblastic Leukemia Cells 3Alfacell's ONCONASE(R) and R-Amphinase Show Anti-Tumor Activity in Chronic Lymphocytic Leukemia and Acute Myeloblastic Leukemia Cells 4Alfacell's ONCONASE(R) and R-Amphinase Show Anti-Tumor Activity in Chronic Lymphocytic Leukemia and Acute Myeloblastic Leukemia Cells 5
(Date:12/16/2009)... Dec. 1 GestureTek Inc. today ... 3.0 - a turnkey, portable, plug and ... exhibits, entertainment and touring promotions. GestureTek is ... patents in camera-enabled gesture recognition technology for ... Guaranteed for quality, the CUBE has TUV, ...
(Date:12/16/2009)... Dec. 8, 2009 National Instruments ... industrial measurement and control, and DENSO Robotics, ... using robotics technology, today announced their collaboration ... with DENSO robotic arms. The collaboration increases ... and flexible manufacturing applications. In today,s trend ...
(Date:12/15/2009)... COLUMBIA, Mo. As soon as babies are ... as jaundice and e-coli. For up to a month, ... Although these infections are often minor, they can lead ... newborns, immune systems, University of Missouri researchers have pinpointed ... lead to an immune-strengthening vaccine. , "We,re trying to ...
Breaking Biology News(10 mins):GestureTek Unveils The CUBE V3 Portable, Plug and Play Interactive Projection Display System for Advertising and Exhibits 2GestureTek Unveils The CUBE V3 Portable, Plug and Play Interactive Projection Display System for Advertising and Exhibits 3National Instruments and DENSO Robotics Collaborate to Address New Applications in Industrial Robotics 2National Instruments and DENSO Robotics Collaborate to Address New Applications in Industrial Robotics 3National Instruments and DENSO Robotics Collaborate to Address New Applications in Industrial Robotics 4National Instruments and DENSO Robotics Collaborate to Address New Applications in Industrial Robotics 5Researchers work on vaccine to improve immune system in newborns 2The Consumers Role in Medication Safety An Interactive Discussion with a Pharmacist on Live TV 49204 1The Consumers Role in Medication Safety An Interactive Discussion with a Pharmacist on Live TV 49204 2Chindex International and Vital Images Sign Reseller Agreement 49200 1Chindex International and Vital Images Sign Reseller Agreement 49200 2Chindex International and Vital Images Sign Reseller Agreement 49200 3Chindex International and Vital Images Sign Reseller Agreement 49200 4Chindex International and Vital Images Sign Reseller Agreement 49200 5Tarrant County Hospital Takes Top Quality Award in Texas 49196 1Tarrant County Hospital Takes Top Quality Award in Texas 49196 2Tarrant County Hospital Takes Top Quality Award in Texas 49196 3
... of brain cells less than half the size of a pencil ... and when it's time to go to sleep. The same cells ... time zones. , The human circadian clock, comprised of about 20,000 ... brain about 30 years ago. Now, a researcher at the University ...
... into believing that our senses, thoughts, feelings and ... brain cells, or neurons, each responsible for relaying ... neurons release a neurotransmitter that excites a neighboring ... brain activity, or they dispatch a signal that ...
... class of virus that infects bacteria by injecting its ... into the driving force behind this poorly understood injection ... occur through the release of pressure accumulated within the ... as bacteriophages) are formed of a capsid structure, or ...
Other Biology News:The circadian clock: Understanding nature's timepiece 2Researchers make surprise discovery that some neurons can transmit three signals at once 2Researchers make surprise discovery that some neurons can transmit three signals at once 3Basis for DNA ejection from single phage particles 2
Mouse monoclonal [HL-37] to HLA DQ1 + HLA DQ3 ( Abpromise for all tested applications)....
Request Info...
Unit Definition: 1 U corresponds to the amount of enzyme which produces 1 mol protons per minute at pH 5.5 and 30C (peptin from citrus peel, Fluka-No. 76280, as substrate)...
... This product is expected to ... mammalian species but has not been ... single precipitin line against partially purified ... to react with all forms of ...
Biology Products: